동남권원자력의학원 의료진소개

최철원

최철원

전문진료분야

유방암, 뇌종양, 육종, 림프종

학력사항

전북대학교 의학과/충북대학교 의학과 석사/동아대학교 의학과 박사

경력

최철원 경력사항으로 연도별 경력내용 제공
2004년 - 2005년 한국원자력의학원 수련의
2005년 - 2009년 한국원자력의학원 전공의
2009년 - 2012년 공중보건의
2012년 - 현재 동남권원자력의학원 방사선종양학과 주임과장
2015년 동남권원자력의학원 방사선비상진료센터장

주요활동

  • 대한방사선종양학회 정회원
  • 대한방사선종양학회 부산울산경남 지회
  • 대한암학회
  • 한국임상암학회
  • 미국 방사선종양학회(ASTRO)
  • 미국 암학회 (ASCO)
  • 유럽 암학회 (ECC)

연구업적

  • Choi CW, Kim MS, Cho CK, et al. ‘Locally Advanced, Unresectable Pancreatic Cancer Treated by Stereotactic Radiation Therapy’, J Korean Soc Ther Radiol Oncol 2006;24:11-20.
  • Choi CW, Kim MS, Yoo SY, et al. ‘The Clinicopathological Factors That Determine a Local Recurrence of Rectal Cancers That Have Been Treated with Surgery and Chemoradiotherapy’, J Korean Soc Ther Radiol Oncol 2006;24:255-262.
  • Seo YS, Cho CK, Yoo SY, Kim MS, Yang KM, Yoo HJ, Choi CW, Lee KH, Lee ED, Rhu SY, Choi SC, Kim MH, Kim BJ, ‘Accelerated Hyperfractionated Radiotherapy for Locally Advanced Uterine Cervix Cancers’, J Korean Soc Ther Radiol Oncol 2008;26(1):24-34.
  • Kim JE, Kim MS, Kang CM, Kim JI, Shin HK, Choi CW, Seo YS, Ji YH, ‘The Use of MTT Assay, In Vitro and Ex Vivo, to Predict the Radiosensitivity of Colorectal Cancer’, J Korean Soc Ther Radiol Oncol 2008;26(3):166-172.
  • Kang JK, Kim MS, Choi CW, Jeong SY, Yoo SY, Cho, CK, Yang KM, Yoo HJ, Cheon GJ, Shin YJ, Seo YS, ‘The Usefulness of 18F-FDG PET/CT for Predicting the Response of Locally Advanced Rectal Cancer to Neoadjuvant Chemoradiation Therapy’, J Korean Soc Ther Radiol Oncol 2009:27(3):111-119.
  • Kim MS, Choi C, Yoo S, Cho C, Seo Y, Ji Y, et al. Stereotactic body radiation therapy in patients with pelvic recurrence from rectal carcinoma. Japanese journal of clinical oncology. 2008 Oct;38(10):695-700.
  • Choi CW, Cho CK, Yoo SY, Kim MS, Yang KM, Yoo HJ, et al. Image-guided stereotactic body radiation therapy in patients with isolated para-aortic lymph node metastases from uterine cervical and corpus cancer. International journal of radiation oncology, biology, physics. 2009 May 1;74(1):147-53.
  • Kim MS, Kang JK, Cho CK, Choi CW, Seo YS, Hwang DY, et al. Three-fraction stereotactic body radiation therapy for isolated liver recurrence from colorectal cancer. Tumori. 2009 Jul-Aug;95(4):449-54.
  • Kim MS, Yoo SY, Cho CK, Yoo HJ, Choi CW, Seo YS, et al. Stereotactic body radiation therapy using three fractions for isolated lung recurrence from colorectal cancer. Oncology. 2009;76(3):212-9.
  • Seo Y, Kim MS, Yoo S, Cho C, Yang K, Yoo H, et al. Stereotactic body radiation therapy boost in locally advanced pancreatic cancer. International journal of radiation oncology, biology, physics. 2009 Dec 1;75(5):1456-61.
  • Seo Y, Yoo H, Yoo S, Cho C, Yang K, Kim MS, et al. Robotic system-based fractionated stereotactic radiotherapy in locally recurrent nasopharyngeal carcinoma. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2009 Dec;93(3):570-4.
  • Seo YS, Kim MS, Yoo SY, Cho CK, Choi CW, Kim JH, et al. Preliminary result of stereotactic body radiotherapy as a local salvage treatment for inoperable hepatocellular carcinoma. Journal of surgical oncology. 2010 Sep 1;102(3):209-14. PubMed PMID: 20740576. Epub 2010/08/27. eng.
  • Kang JK, Cho CK, Choi CW, Yoo S, Kim MS, Yang K, et al. Image-guided stereotactic body radiation therapy for localized prostate cancer. Tumori. 2011 Jan-Feb;97(1):43-8.
  • Paik EK, Kim MS, Choi CW, Jang WI, Lee SH, Choi SH, et al. Dosimetric comparison of volumetric modulated arc therapy with robotic stereotactic radiation therapy in hepatocellular carcinoma. Radiation oncology journal. 2015 Sep;33(3):233-41.
  • Park HJ, Chang AR, Seo Y, Cho CK, Jang WI, Kim MS, et al. Stereotactic Body Radiotherapy for Recurrent or Oligometastatic Uterine Cervix Cancer: A Cooperative Study of the Korean Radiation Oncology Group (KROG 14-11). Anticancer research. 2015 Sep;35(9):5103-10.
  • Park SJ, Heo K, Choi C, Yang K, Adachi A, Okada H, et al. Carbon ion irradiation abrogates Lin28B-induced X-ray resistance in melanoma cells. Journal of radiation research. 2017 Nov 1;58(6):765-71. PubMed PMID: 28482074.
  • Bae SH, Kim M-S, Jang W, Kim J, Kim W, Kim J, et al. Multicenter Planning Comparison of Stereotactic Body Radiotherapy for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis (KROG 16-17). Journal of Liver Cancer. 2018 09/15;18:130-41.
  •  Choi CW, Jeong MH, Park YS, Son CH, Lee HR, Koh EK. Combination Treatment of Stereotactic Body Radiation Therapy and Immature Dendritic Cell Vaccination for Augmentation of Local and Systemic Effects. Cancer research and treatment : official journal of Korean Cancer Association. 2018 Jun 6.
  • Yu T, Choi CW, Kim KS. Treatment outcomes of stereotactic ablative radiation therapy for non-spinal bone metastases: focus on response assessment and treatment indication. The British journal of radiology. 2019 Jul;92(1099):20181048.
  • Jang WI, Bae SH, Kim MS, Han CJ, Park SC, Kim SB, et al. A phase 2 multicenter study of stereotactic body radiotherapy for hepatocellular carcinoma: Safety and efficacy. Cancer. 2019 Nov 20.